跳至主要内容
临床试验/NCT01652404
NCT01652404Unknown3 期

PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial

Hunan Children's Hospital1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2011年3月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
入组人数
600
试验地点
1
主要终点
Average antibiotics duration

研究概览

简要总结

The purpose of this study is to give conclusive evidence on whether serial PCT (Procalcitonin) measurements can facilitate individual decision-making and shorten antibiotic treatment duration in patients with sepsis in the pediatric ICU (Intensive Care Unit).

详细描述

In this study, the investigators aimed to design a multi-center trial addressing aforementioned flaws. The investigators will set stricter inclusion criteria, collect complete data on relapse or secondary infection, and include sufficient number of patients to show non-inferiority to conventional therapy by a delta margin of 10% [11]. The investigators aimed to give conclusive evidence on whether serial PCT measurements can facilitate individual decision-making and shorten antibiotic treatment duration in patients with sepsis in the pediatric ICU.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 15 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •All patients with laboratory- or image-confirmed severe infection at admission or during stay in pediatric ICU will be eligible for inclusion.
  • •* Definition of laboratory- or image-confirmed severe infection:
  • •Two or more of four signs of inflammation:
  • •Temperature >38.3℃ or <36℃
  • •Heart rate > 90 beats/min
  • •Respiratory rate >20 breaths/min or PaCO2 (Arterial pressure of carbon dioxide) < 32 mmHg
  • •WBC (White Blood Cell count) > 12,000 cells/mm3, <4000 cells/mm3, or >5% band-form WBC
  • •Initial Procalcitonin > 0.5 ng/mL
  • •Presence of either laboratory or image evidence of infection
  • •Laboratory evidence: Sign of inflammation in urine, CSF (Cerebrospinal Fluid), ascites, pleural effusion or local abscess
  • •Image evidence: Compatible findings on Chest X ray, ultrasound, CT (Computed Tomography), MR image (Magnetic Resonance Image)

排除标准

  • •Age greater than 15 years or less than 1 month
  • •Known pregnancy
  • •Expected ICU stay less than 3 days
  • •Neutropenia: ANC (Absolute Neutrophil Count) <500/mm3
  • •Specific infections for which long-term antibiotic treatment is strongly recommended:
  • •Lobar pneumonia or empyema
  • •Bacterial meningitis
  • •Osteomyelitis
  • •Infective endocarditis
  • •Local abscess
  • •Mediastinitin

研究组 & 干预措施

Procalcitonin-guided treatment

Experimental

The duration of antibiotics will be determined by the procalcitonin levels.

干预措施: Procalcitonin-guided treatment (Behavioral)

Conventional treatment

Active Comparator

The duration of antibiotics will be determined by the treating physician.

干预措施: Conventional treatment (Behavioral)

结局指标

主要结局

Average antibiotics duration

时间窗: 28 days

Efficacy endpoint

28-day mortality rate

时间窗: 28 days

Safety endpoint

次要结局

  • Proportion of antibiotics use in both arms(28 days)
  • Length of ICU stay(90 days)
  • Recurrence of fever within 72 hours of antibiotics discontinuation(28 days)
  • SOFA score (Sequential Organ Failure Assessment score)(28 days)
  • Reinfection rate between 72-hours and 28 days post antibiotics discontinuation(28 days)
  • 90-day all-cause mortality(90 days)
  • 90-day readmission rate(90 days)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验